Search

Now showing items 11-18 of 18

Social capital: Implications for neurology.

Reyes, S; Giovannoni, G; Thomson, A (2019-01)

Social capital (SC) is a broad term that encompasses the many resources derived from social connections. The contemporary study of SC in public health has deep roots in the related fields of sociology, economics, and ...

Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.

Scolding, N; Barnes, D; Cader, S; Chataway, J; Chaudhuri, A; Coles, A; Giovannoni, G; Miller, D; Rashid, W; Schmierer, K;... (2015-08)

Visibility and representation of women in multiple sclerosis research.

Thomson, A; Horne, R; Chung, C; Marta, M; Giovannoni, G; Palace, J; Dobson, R (2019-04-09)

OBJECTIVE: To establish the gender distribution of multiple sclerosis (MS) researchers across high-impact neurologic publications, MS-specific journals, and the European Committee for Treatment and Research in MS (ECTRIMS). ...

How to start a blog.

Thomson, A; Raciborska, D; Baker, D; Giovannoni, G (2017-06)

Blogs that address issues of health and medical education run by clinical and research teams can have a profound impact on how patients access and navigate health information. Regularly updated websites are useful tools ...

A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis.

Giovannoni, G; Knappertz, V; Steinerman, JR; Tansy, AP; Li, T; Krieger, S; Uccelli, A; Uitdehaag, BMJ; Montalban, X; Hartung, H-P;... (2020-08-25)

OBJECTIVE: To evaluate efficacy, safety, and tolerability of laquinimod in patients with primary progressive multiple sclerosis (PPMS). METHODS: In the randomized, double-blind, placebo-controlled, phase 2 study, ARPEGGIO ...

ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK.

Jacobs, BM; Schalk, L; Dunne, A; Scalfari, A; Nandoskar, A; Gran, B; Mein, CA; Sellers, C; Spilker, C; Rog, D;... (2023-05-17)

PURPOSE: Genetic studies of multiple sclerosis (MS) susceptibility and severity have focused on populations of European ancestry. Studying MS genetics in other ancestral groups is necessary to determine the generalisability ...

Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?

Baker, D; MacDougall, A; Kang, AS; Schmierer, K; Giovannoni, G; Dobson, R (2022-05-12)

Although there is an ever-increasing number of disease-modifying treatments for relapsing multiple sclerosis (MS), few appear to influence coronavirus disease 2019 (COVID-19) severity. There is concern about the use of ...

CSF neurofilament light chain testing as an aid to determine treatment strategies in MS.

Reyes, S; Smets, I; Holden, D; Carrillo-Loza, K; Christmas, T; Bianchi, L; Ammoscato, F; Turner, B; Marta, M; Schmierer, K;... (2020-11)

OBJECTIVE: To evaluate the use of CSF neurofilament light chain (NfL) measurements in clinical practice as well as their effect on treatment strategies and outcomes in patients with MS. METHODS: This was an observational ...